Fate Therapeutics
Link
fatetherapeutics.com
E-mail
info@fatetherapeutics.com, BD@fatetherapeutics.com
Country
USA
Краткое название
Fate Therapeutics Inc
Headquarters
3535 General Atomics Court Suite 200
Members of the board
Christian Weyer, M.D., M.A.S., President & Chief Executive Officer
Pratik Multani, M.D., M.S., Senior Vice President of Clinical Development
Dan Shoemaker, PH.D., Chief Technology Officer
Scott Wolchko, Chief Financial Officer and Vice President of Operations
Peter Flynn, PH.D., Vice President, Biologics Therapeutics
Cindy Tahl, J.D., Senior Director of Intellectual Property and Corporate Counsel
Scott Thies, PH.D., Senior Director of Stem Cell Biology
Pratik Multani, M.D., M.S., Senior Vice President of Clinical Development
Dan Shoemaker, PH.D., Chief Technology Officer
Scott Wolchko, Chief Financial Officer and Vice President of Operations
Peter Flynn, PH.D., Vice President, Biologics Therapeutics
Cindy Tahl, J.D., Senior Director of Intellectual Property and Corporate Counsel
Scott Thies, PH.D., Senior Director of Stem Cell Biology
Stage of the project
Production
Disease
Blood cancer
Current owners
William Rastetter, PH.D. Chairman
Christian Weyer, M.D., M.A.S.
John Mendelein, PH.D. Vice Chairman
Mark J. Enyedy
Amir Nashat, PH.D.
Robert T. Nelsen
Bryan Roberts, PH.D.
Carl Weissman
Christian Weyer, M.D., M.A.S.
John Mendelein, PH.D. Vice Chairman
Mark J. Enyedy
Amir Nashat, PH.D.
Robert T. Nelsen
Bryan Roberts, PH.D.
Carl Weissman
Technology
Devices, Technologies